← Compounds
ENDO-205
peptide · comparatorInvestigationalNon-hormonal precision peptide targeting endo lesions (pipeline)
Overview
PIPELINE — first-in-class non-hormonal "precision peptide" for endometriosis (EndoCyclic Therapeutics). Designed to eliminate endo lesions directly rather than suppress hormones. FDA IND cleared; entering human trials. Not yet available — a watch-list entry, not a protocol.
How it works
- Targeted elimination of endometriotic lesions (non-hormonal, preclinical)
Dosing
N/A — trial-stage, no established clinical dose.
Cycling
Side effects
- Common
- Warnings
- Investigational — efficacy/safety not established in humans
Used for
No condition evidence rows yet.
Legal / compounding
Investigational
- FDA
- Investigational (IND cleared)
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.